×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Italy Asthma Inhaler Device Market

ID: MRFR/HC/54554-HCR
200 Pages
MRFR Team
February 2026

Italy Asthma Inhaler Device Market Research Report: By Type (Metered Dose Inhalers, Dry Powder Inhalers, Soft Mist Inhalers), By Mode of Operation (Manually Operated Inhaler Devices, Digitally-Operated Inhaler Devices) andBy End User (Hospitals & Clinics, Homecare)- Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Options

Italy Asthma Inhaler Device Market Summary

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

Industry Developments

The Italy Asthma Inhaler Device Market has witnessed significant developments in recent months. Notable companies such as Pfizer, AbbVie, and GlaxoSmithKline are actively engaging in advancements in their asthma inhaler technologies. For instance, Chiesi Farmaceutici announced in August 2023 its ongoing efforts in developing advanced inhalation therapies aimed at improving patient compliance and medication adherence. Additionally, Boehringer Ingelheim has been focusing on research and development projects to enhance drug delivery systems to meet the specific needs of Italian patients. In recent merger and acquisition news, AstraZeneca and Merck & Co finalized their strategic agreement in September 2023 to jointly promote certain respiratory inhalation products across Italy, showcasing a trend of collaboration aimed at innovation in asthma therapies. Over the past few years, Italy has seen a growth in the valuation of asthma inhaler devices, driven by government investments in healthcare technology and rising awareness of respiratory diseases. Furthermore, changes in regulations in 2021 have encouraged better access to new inhaler technologies for patients across the country, impacting market dynamics significantly.

Report Scope

Report Scope:
Report Attribute/Metric Source:Details
MARKET SIZE 201847.04(USD Million)
MARKET SIZE 202451.74(USD Million)
MARKET SIZE 2035114.0(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR) 7.445% (2025 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
MARKET FORECAST PERIOD2025 - 2035
HISTORICAL DATA2019 - 2024
MARKET FORECAST UNITSUSD Million
KEY COMPANIES PROFILEDPfizer, AbbVie, GlaxoSmithKline, Roche, Boehringer Ingelheim, Chiesi Farmaceutici, BristolMyers Squibb, Mylan, Novartis, Sanofi, HoffmannLa Roche, Otonomy, Teva Pharmaceutical Industries, AstraZeneca, Merck & Co
SEGMENTS COVEREDType, Mode of Operation, End User
KEY MARKET OPPORTUNITIESIncreasing prevalence of asthma, Adoption of smart inhalers, Growth in home healthcare, Enhanced availability of telemedicine, Rising aging population with respiratory issues
KEY MARKET DYNAMICSrising asthma prevalence, growing healthcare awareness, technological advancements in devices, increasing focus on patient compliance, expansion of insurance coverage
COUNTRIES COVEREDItaly
Leave a Comment

FAQs

What is the expected market size of the Italy Asthma Inhaler Device Market in 2024?

The market size of the Italy Asthma Inhaler Device Market is expected to be valued at 51.74 million USD in 2024.

What is the projected market size for the Italy Asthma Inhaler Device Market by 2035?

By 2035, the Italy Asthma Inhaler Device Market is projected to reach a value of 114.0 million USD.

What is the expected compound annual growth rate (CAGR) for the Italy Asthma Inhaler Device Market from 2025 to 2035?

The expected CAGR for the Italy Asthma Inhaler Device Market from 2025 to 2035 is 7.445%.

Which type of inhaler is expected to have the largest market share in 2024?

In 2024, the Metered Dose Inhalers segment is expected to have the largest market share, valued at 20.52 million USD.

What is the expected market size for Dry Powder Inhalers in 2035?

The market size for Dry Powder Inhalers is expected to be 37.68 million USD by 2035.

Who are the major players in the Italy Asthma Inhaler Device Market?

Major players in the market include companies such as Pfizer, AbbVie, GlaxoSmithKline, and Roche.

What opportunities and trends are shaping the Italy Asthma Inhaler Device Market?

Key opportunities include advancements in inhaler technology and increasing awareness about asthma management.

What is the anticipated market growth rate for the Metered Dose Inhalers segment from 2025 to 2035?

The Metered Dose Inhalers segment is expected to show significant growth, reaching 45.76 million USD by 2035.

How much is the Soft Mist Inhalers segment expected to be valued in 2035?

The Soft Mist Inhalers segment is expected to be valued at 30.56 million USD by 2035.

What factors are driving the growth of the Italy Asthma Inhaler Device Market?

Growth drivers include the increasing prevalence of asthma and greater product innovations in inhaler design.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions